Future Match Making: When Pediatric Oncology Meets Organoid Technology

Area of Science:

• Developmental Biology
• Cancer Biology
• Epigenetics

Background:

• Childhood cancers differ fundamentally from adult cancers, often arising from epigenetic dysregulation rather than accumulated mutations.
• Understanding these unique biological differences is critical for advancing pediatric oncology.
• Patient-derived cancer organoids (tumoroids) are valuable in vitro models that mimic tumor complexity.

Purpose of the Study:

• To highlight the underutilization of cancer organoid technology in childhood cancer research.
• To emphasize the potential of tumoroids for unraveling pediatric cancer biology.
• To present the current status of applying organoid technology to pediatric cancers.

Main Methods:

• Review of current literature on cancer organoid development and application.
• Analysis of the technological gap in applying organoids to pediatric cancers.
• Discussion of the state-of-the-art in pediatric cancer organoid research.

Main Results:

• Cancer organoids show promise in recapitulating patient-specific tumor features, including heterogeneity and plasticity.
• There is a significant lag in the adoption and technological transfer of organoid technology for childhood cancers compared to adult cancers.
• Organoids offer a unique platform for studying the distinct developmental origins of pediatric tumors.

Conclusions:

• Cancer organoids represent a crucial, yet underused, tool for advancing the understanding of pediatric cancer biology.
• Bridging the technological gap in organoid application is essential for improving therapeutic strategies for childhood cancers.
• Further development and application of tumoroids are needed to unlock their full potential in pediatric oncology.